D-1243-2019 Class III Terminated

Recalled by LUPIN SOMERSET — Somerset, NJ

FDA drug recall D-1243-2019 was initiated by LUPIN SOMERSET on Apr 10, 2019 and is designated Class III. Reason for recall: Failed Impurities/Degradation Specifications The recall status is terminated (terminated Oct 14, 2022). Affected quantity: 17,328 bottles.

Recall details

Product Type
Drugs
Report Date
May 1, 2019
Initiation Date
Apr 10, 2019
Termination Date
Oct 14, 2022
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
17,328 bottles

Product description

Morphine Sulfate Extended-Release Tablets, 15 mg, 100-count bottles, Rx Only, Manufactured by: Novel Laboratories, Inc. Somerset, NJ 08873 Manufactured for: Lupin Pharmaceuticals, Inc. Baltimore, MD 21202, NDC 43386-540-01

Reason for recall

Failed Impurities/Degradation Specifications

Distribution pattern

Product was shipped to 5 wholesalers and one Supermarket Chain who may have further distributed the product throughout the United States.

Code information

Lot#: S700220, Exp. Apr 30 2019; S700604, Exp. July 31 2019; S800326, Exp. Mar 31 2020

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-1243-2019
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-1243-2019. Report a data issue: hello@regdatalab.com.